Show simple item record

Management of retinopathy of prematurity with cryotherapy

dc.contributor.authorKaracorlu, M
dc.contributor.authorGezer, A
dc.contributor.authorSezen, F
dc.contributor.authorSerifoglu, I
dc.date.accessioned2021-03-03T08:51:42Z
dc.date.available2021-03-03T08:51:42Z
dc.date.issued1999
dc.identifier.citationGezer A., Sezen F., Serifoglu I., Karacorlu M., "Management of retinopathy of prematurity with cryotherapy", EUROPEAN JOURNAL OF OPHTHALMOLOGY, cilt.9, sa.1, ss.49-52, 1999
dc.identifier.issn1120-6721
dc.identifier.otherav_19eb2062-e54a-4e27-a05c-e0b38c21ff11
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/22691
dc.description.abstractPurpose. Newborns at risk for retinopathy of prematurity (ROP) should be examined 4 to 8 weeks postpartum. Various treatment modalities including cryotherapy, are proposed to ablate the retinal proliferation, when serious and progressive ROP is detected. This study stresses as main risk factors low birth weight and short gestational age as predisposing to ROP and the efficiency of cryotherapy as a treatment modality.
dc.language.isoeng
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectCerrahi Tıp Bilimleri
dc.subjectGöz Hastalıkları ve Cerrahisi
dc.subjectOFTALMOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.titleManagement of retinopathy of prematurity with cryotherapy
dc.typeMakale
dc.relation.journalEUROPEAN JOURNAL OF OPHTHALMOLOGY
dc.contributor.department, ,
dc.identifier.volume9
dc.identifier.issue1
dc.identifier.startpage49
dc.identifier.endpage52
dc.contributor.firstauthorID122278


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record